NCT07211776Phase 3Active not recruiting

A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

Study sponsor: Zai Lab (Shanghai) Co., Ltd.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-03-14Estimated
Enrollment · participants108Actual
Source updated2026-09-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 99 participants (planned). After: 108 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source